These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6504106)

  • 1. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
    Wang EE; Prober CG; Manson B; Corey M; Levison H
    N Engl J Med; 1984 Dec; 311(26):1653-8. PubMed ID: 6504106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose ibuprofen in patients with cystic fibrosis.
    Konstan MW; Byard PJ; Hoppel CL; Davis PB
    N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial.
    Suri R; Metcalfe C; Wallis C; Bush A
    Respir Med; 2007 Feb; 101(2):254-60. PubMed ID: 16806875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic.
    Olesen HV; Nielsen LP; Schiotz PO
    Pediatr Pulmonol; 2006 Dec; 41(12):1197-204. PubMed ID: 17058280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
    Efrati O; Mei-Zahav M; Rivlin J; Kerem E; Blau H; Barak A; Bujanover Y; Augarten A; Cochavi B; Yahav Y; Modan-Moses D
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcaligenes infection in cystic fibrosis.
    Tan K; Conway SP; Brownlee KG; Etherington C; Peckham DG
    Pediatr Pulmonol; 2002 Aug; 34(2):101-4. PubMed ID: 12112775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM; McGaw J; Taylor CJ; Everard ML
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
    Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
    J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
    Houstĕk J; Zapletal A; Samánek M; Vávrová V
    Czech Med; 1979; 2(1-2):1-10. PubMed ID: 527420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation.
    Ren CL; Brucker JL; Rovitelli AK; Bordeaux KA
    Pediatr Pulmonol; 2006 Apr; 41(4):345-9. PubMed ID: 16496336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction.
    Thomson MA; Quirk P; Swanson CE; Thomas BJ; Holt TL; Francis PJ; Shepherd RW
    Nutrition; 1995; 11(4):350-4. PubMed ID: 8580575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome.
    Yazar A; Atis S; Konca K; Pata C; Akbay E; Calikoglu M; Hafta A
    Am J Gastroenterol; 2001 May; 96(5):1511-6. PubMed ID: 11374691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections.
    Termoz A; Touzet S; Bourdy S; Decullier E; Bouveret L; Colin C; Nove-Josserand R; Reix P; Cracowski C; Pin I; Bellon G; Durieu I
    Pediatr Pulmonol; 2008 Sep; 43(9):908-15. PubMed ID: 18680182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.